BioCentury
ARTICLE | Company News

Anaconda Pharma, Biota Pharmaceuticals deal

March 16, 2015 7:00 AM UTC

Biota is acquiring Anaconda for $8 million in cash and 3.5 million Biota shares, valued at $8.7 million based on Biota’s close of $2.48 on Feb. 25, before the deal was announced. Anaconda shareholders are eligible for up to $30 million in clinical and regulatory milestones, plus low single-digit royalties. ...